Evaluation of everolimus (EVE) in HER2+advanced breast cancer (BC) with activated PI3K/mTOR pathway: Exploratory biomarker observations from the BOLERO-3 trial


Jerusalem G., Andre F., Chen D., Robinson D., Ozguroglu M., Lang I., ...Daha Fazla

EUROPEAN JOURNAL OF CANCER, cilt.49, 2013 (SCI İndekslerine Giren Dergi) identifier

  • Cilt numarası: 49
  • Basım Tarihi: 2013
  • Dergi Adı: EUROPEAN JOURNAL OF CANCER